Wednesday, August 16, 2017 10:03:35 AM
1. All paid promotions are suspect in my opinion. Have you ever seen one that wasn't positive?
2. When this piece was written there were 30mm shares outstanding, not 1 billion.
3. Much of the value that they placed on the stock was predicated on OvaDX approval - OvaDX is no where near FDA submission. Technically Arrayit doesn't even own the IP anymore - Avant does.
4. There is a lot that COULD happen but I don't see the company doubling or tripling sales any time soon (basing this on an expected $6-$10mm revenue figure for 2016/2017). By the company's own admission, their growth mirrors Illumina's which was in the 10% range.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM